Hyaluronan binding motifs of USP17 and SDS3 exhibit anti-tumor activity

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Ramakrishna, Suresh ^a   Suresh, Bharathi ^a   Bae, Su Mi ^b   Ahn, Woong Shick ^b   Lim, Key Hwan ^a   Baek, Kwang Hyun ^a  

^a CHA University   (South Korea)

^b The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CETYLPYRIDINIUM SALT; CYSTEINE PROTEINASE; HISTONE DEACETYLASE; HYALURONIC ACID; HYALURONIC ACID BINDING PROTEIN; SUPPRESSOR OF DEFECTIVE SILENCING 3; UBIQUITIN SPECIFIC PROCESSING PROTEASE 17; UNCLASSIFIED DRUG;

ANCHORAGE INDEPENDENT GROWTH; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; BINDING AFFINITY; CANCER INHIBITION; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; HYALURONAN BINDING MOTIF; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION;

AMINO ACID SEQUENCE; BASE SEQUENCE; CELL PROLIFERATION; ENDOPEPTIDASES; ENZYME ACTIVATION; HELA CELLS; HUMANS; HYALURONIC ACID; MOLECULAR SEQUENCE DATA; NEOPLASMS; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; REPRESSOR PROTEINS; SEQUENCE DELETION;

EID: 84861473969     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0037772     Document Type: Article

References (43)

1. Ciechanover A, (1998) ubiquitin-proteasome pathway: on protein death and cell life. EMBO J 17: 7151-7160.
2. Koegl M, Hoppe T, Schlenker S, Ulrich HD, Mayer TU, et al. (1999) A novel ubiquitination factor, E4, is involved in multiubiquitin chain assembly. Cell 96: 635-644.
3. Amerik AY, Hochstrasser M, (2004) Mechanism and function of deubiquitinating enzymes. Biochim Bio phys Acta 1695: 189-207.
4. Baek KH, Kim MS, Kim YS, Shin JM, Choi KH, (2004) DUB-1A, a novel subfamily member of deubiquitinating enzyme, is polyubiquitinated and cytokine inducible in B-lymphocytes. J Biol Chem 279: 2368-2376.
5. Hussain S, Zhang Y, Galardy PJ, (2009) DUBs and cancer: the role of deubiquitinating enzymes as oncogenes, non-oncogenes and tumor suppressors. Cell Cycle 8: 1688-1697.
6. Ramakrishna S, Suresh B, Baek KH, (2011) The role of deubiquitinating enzymes in apoptosis. Cell Mol Life Sci 68: 15-26.
7. Baek KH, (2006) Cytokine-regulated protein degradation by the ubiquitination system. Curr Protein Pept Sci 7: 171-177.
8. Burrows JF, McGrattan MJ, Rascle A, Humbert M, Baek KH, et al. (2004) DUB-3, a cytokine-inducible deubiquitinating enzyme that blocks proliferation. J Biol Chem 279: 13993-14000.
9. Burrows JF, Kelvin AA, McFarlane C, Burden RE, McGrattan MJ, et al. (2009) USP17 regulates Ras activation and cell proliferation by blocking RCE1 activity. J Biol Chem 284: 9587-9595.
10. Burrows JF, McGrattan MJ, Johnston JA, (2005) The DUB/USP17 deubiquitinating enzymes, a multigene family within a tandemly repeated sequence. Genomics 85: 524-529.
11. Ramakrishna S, Suresh B, Lee EJ, Lee HJ, Ahn WS, et al. (2011) K63 specific deubiquitination of SDS3 by USP17 regulates HDAC activity. J Biol Chem 286: 10505-10514.
12. de la Vega M, Kelvin AA, Dunican DJ, McFarlane C, Burrows JF, et al. (2011) The deubiquitinating enzyme USP17 is essential for GTPase subcellular localization and cell motility. Nat Commun 2: 259.
13. Shin JM, Yoo KJ, Kim MS, Kim D, Baek KH, (2006) Hyaluronan-and RNA-binding deubiquitinating enzymes of USP17 family members associated with cell viability. BMC Genomics 7: 292.
14. Yang B, Hall CL, Yang BL, Savani RC, Turley EA, (1994) Identification of a common hyaluronan binding motif in the hyaluronan binding proteins RHAMM, CD44 and link protein. EMBO J 13: 286-296.
15. Knudson CB, Knudson W, (1993) Hyaluronan-binding proteins in development, tissue homeostasis, and disease. FASEB J 7: 1233-1241.
16. Toole BP, (2004) Hyaluronan: from extracellular glue to pericellular cue. Nat Rev Cancer 4: 528-539.
17. Ripellino JA, Bailo M, Margolis RU, Margolis RK, (1988) Light and electron microscopic studies on the localization of hyaluronic acid in developing rat cerebellum. J Cell Biol 106: 845-855.
18. Ripellino JA, Margolis RU, Margolis RK, (1989) Immunoelectron microscopic localization of hyaluronic acid-binding region and link protein epitopes in brain. J Cell Biol 108: 1899-1907.
19. Eggli PS, Graber W, (1995) Association of hyaluronan with rat vascular endothelial and smooth muscle cells. J Histochem Cytochem 43: 689-697.
20. Hascall VC, Majors AK, De La Motte CA, Evanko SP, Wang A, et al. (2004) Intracellular hyaluronan: a new frontier for inflammation? Biochim Biophys Acta 1673: 3-12.
21. Grammatikakis N, Grammatikakis A, Yoneda M, Yu Q, Banerjee SD, et al. (1995) A novel glycosaminoglycan-binding protein is the vertebrate homologue of the cell cycle control protein, Cdc37. J Biol Chem 270: 16198-16205.
22. Deb TB, Datta K, (1996) Molecular cloning of human fibroblast hyaluronic acid-binding protein confirms its identity with P-32, a protein co-purified with splicing factor SF2. Hyaluronic acid-binding protein as P-32 protein, co-purified with splicing factor SF2. J Biol Chem 271: 2206-2212.
23. Hofmann M, Fieber C, Assmann V, Gottlicher M, Sleeman J, et al. (1998) Identification of IHABP, a 95 kDa intracellular hyaluronate binding protein. J Cell Sci 111 (Pt 12): 1673-1684.
24. Zhang S, Chang MC, Zylka D, Turley S, Harrison R, et al. (1998) The hyaluronan receptor RHAMM regulates extracellular-regulated kinase. J Biol Chem 273: 11342-11348.
25. Assmann V, Marshall JF, Fieber C, Hofmann M, Hart IR, (1998) The human hyaluronan receptor RHAMM is expressed as an intracellular protein in breast cancer cells. J Cell Sci 111 (Pt 12): 1685-1694.
26. Huang L, Grammatikakis N, Yoneda M, Banerjee SD, Toole BP, (2000) Molecular characterization of a novel intracellular hyaluronan-binding protein. J Biol Chem 275: 29829-29839.
27. Evanko SP, Wight TN, (1999) Intracellular localization of hyaluronan in proliferating cells. J Histochem Cytochem 47: 1331-1342.
28. Majors AK, Austin RC, de la Motte CA, Pyeritz RE, Hascall VC, et al. (2003) Endoplasmic reticulum stress induces hyaluronan deposition and leukocyte adhesion. J Biol Chem 278: 47223-47231.
29. Bartolazzi A, Peach R, Aruffo A, Stamenkovic I, (1994) Interaction between CD44 and hyaluronate is directly implicated in the regulation of tumor development. J Exp Med 180: 53-66.
30. Yu Q, Toole BP, Stamenkovic I, (1997) Induction of apoptosis of metastatic mammary carcinoma cells in vivo by disruption of tumor cell surface CD44 function. J Exp Med 186: 1985-1996.
31. Peterson RM, Yu Q, Stamenkovic I, Toole BP, (2000) Perturbation of hyaluronan interactions by soluble CD44 inhibits growth of murine mammary carcinoma cells in ascites. Am J Pathol 156: 2159-2167.
32. Ahrens T, Sleeman JP, Schempp CM, Howells N, Hofmann M, et al. (2001) Soluble CD44 inhibits melanoma tumor growth by blocking cell surface CD44 binding to hyaluronic acid. Oncogene 20: 3399-3408.
33. Liu N, Lapcevich RK, Underhill CB, Han Z, Gao F, et al. (2001) Metastatin: a hyaluronan-binding complex from cartilage that inhibits tumor growth. Cancer Res 61: 1022-1028.
34. Gao F, Cao ML, Wang L, (2004) Brain hyaluronan binding protein inhibits tumor growth. Chin Med J (Engl) 117: 1072-1078.
35. Xu XM, Chen Y, Chen J, Yang S, Gao F, et al. (2003) A peptide with three hyaluronan binding motifs inhibits tumor growth and induces apoptosis. Cancer Res 63: 5685-5690.
36. Ghatak S, Misra S, Toole BP, (2002) Hyaluronan oligosaccharides inhibit anchorage-independent growth of tumor cells by suppressing the phosphoinositide 3-kinase/Akt cell survival pathway. J Biol Chem 277: 38013-38020.
37. Zoltan-Jones A, Huang L, Ghatak S, Toole BP, (2003) Elevated hyaluronan production induces mesenchymal and transformed properties in epithelial cells. J Biol Chem 278: 45801-45810.
38. Toole BP, Zoltan-Jones A, Misra S, Ghatak S, (2005) Hyaluronan: a critical component of epithelial-mesenchymal and epithelial-carcinoma transitions. Cells Tissues Organs 179: 66-72.
39. Acharya S, Rodriguez IR, Moreira EF, Midura RJ, Misono K, et al. (1998) SPACR, a novel interphotoreceptor matrix glycoprotein in human retina that interacts with hyaluronan. J Biol Chem 273: 31599-31606.
40. Toole BP, Ghatak S, Misra S, (2008) Hyaluronan oligosaccharides as a potential anticancer therapeutic. Curr Pharm Biotechnol 9: 249-252.
41. Lesley J, Hascall VC, Tammi M, Hyman R, (2000) Hyaluronan binding by cell surface CD44. J Biol Chem 275: 26967-26975.
42. Alland L, David G, Shen-Li H, Potes J, Muhle R, et al. (2002) Identification of mammalian Sds3 as an integral component of the Sin3/histone deacetylase corepressor complex. Mol Cell Biol 22: 2743-2750.
43. David G, Dannenberg JH, Simpson N, Finnerty PM, Miao L, et al. (2006) Haploinsufficiency of the mSds3 chromatin regulator promotes chromosomal instability and cancer only upon complete neutralization of p53. Oncogene 25: 7354-7360.